Since CCR7 signalling in normal immune cells mediates a pro-survival signal through the PKB/AKT cascade (Pilkington et al, 2004; Sanchez-Sanchez et al, 2004), it is also possible that this pathway may influence outcome in response to treatment in head and neck cancers. This evidence concerns the gene AKT1 and head and neck cancer.